Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,601,957
+$203,043 QoQ
Shares Held
10,340
-6.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,751
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Valmark Advisers, Inc. holds $25,445,603 across 11 Drug Manufacturers - General names. ABBV ranks #5 (10.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,846 | $7,011,868 | |
| 2 | JNJ |
Johnson & Johnson
|
23,608 | $5,995,723 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,899 | $3,456,521 | |
| 4 | AMGN |
Amgen Inc
|
8,535 | $3,090,694 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
10,340 | $2,601,957 | |
| 6 | NVS |
Novartis AG
|
8,050 | $1,261,596 | |
| 7 | PFE |
Pfizer Inc
|
33,525 | $807,282 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
3,261 | $411,994 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,601,957 | 10,340 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,398,914 | 11,030 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $2,574,396 | 11,267 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $2,630,757 | 11,362 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $2,077,644 | 11,193 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $2,045,543 | 9,763 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,515,247 | 8,527 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,477,742 | 7,483 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $1,130,831 | 6,593 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $1,127,381 | 6,191 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $978,790 | 6,316 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $1,019,868 | 6,842 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $862,945 | 6,405 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,029,848 | 6,462 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $943,640 | 5,839 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $791,704 | 5,899 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $874,237 | 5,708 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $863,559 | 5,327 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $404,981 | 2,991 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $300,202 | 2,783 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $362,250 | 3,216 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $308,318 | 2,849 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $237,980 | 2,221 | Shares | Sole | 2021-02-03 | |
| No filing history on record for this holder in this stock. | ||||||